![JAK-IN-4 0701 7aR)-6-{6-amino-8-[(4-chlorophenyl)sulfanyl]-9H-purin-9-yl}-7-methoxy-2-oxo-hexahydro-2λ⁵-furo[3](https://cdn.shopify.com/s/files/1/0389/1897/9723/products/M27947_1636008512.gif?v=1636008513)
Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
7aR)-6-{6-amino-8-[(4-chlorophenyl)sulfanyl]-9H-purin-9-yl}-7-methoxy-2-oxo-hexahydro-2λ⁵-furo[3
Fenamic acid is a chloride channel blocker
Odanacatib treated OC accumulates labeled degraded bone matrix proteins in CatK containing vesicles
Endomorphin 1 and Endomorphin 2 compete both μ1 and μ2 receptor sites quite potently
and 160 μM for PANC-1
JAK-IN-4 0701 7aR)-6-{6-amino-8-[(4-chlorophenyl)sulfanyl]-9H-purin-9-yl}-7-methoxy-2-oxo-hexahydro-2λ⁵-furo[3JAK IN 4 is a prodrug of a JAK inhibitor, effective in murine collagen induced arthritis model. Product information CAS Number: 1400877 37 3 Molecular Weight: 464. 32 Formula: C18H19N4Na2O6P Chemical Name: disodium 4 {[(2R,3R) 3 hydroxy 1 (phosphonatooxy)butan 2 yl]amino} 6 phenylpyrrolo[1,2 b]pyridazine 3 carboxamide Smiles: [Na+].[Na+]. C[C@@H](O)[C@@H](COP([O ])([O ])=O)NC1C2=CC(=CN2N=CC=1C(N)=O)C1=CC=CC=C1 InChiKey: HWLNKNUKKZSFDI XGVFAZNSSA L